Neurizon Therapeutics LimitedASX: NUZ

Prospectus

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 58 pages · English

Summary by 6ix AI

Neurizon Therapeutics Limited has filed a prospectus detailing offers for new options to investors, specifically through Placement and SPP Options Offers. The prospectus outlines the terms of these offers, including the requirement for shareholder approval and the intended quotation on the ASX. It emphasizes that the new options are speculative investments and advises potential investors to seek professional advice.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 Prospectus Placement Options Offer: an offer to Placement Participants of one (1) New Option for every one (1) Placement Share issued, or to be issued (subject to Shareholder approval), to them under the Placement. The Closing Date for the Placement...

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases